HOUSTON/LONDON - Baker Hughes (NASDAQ:BKR) announced Friday the final closing of its joint venture with Cactus, Inc. for its surface pressure control (SPC) product line, generating $344.5 million in ...

The first half of the year will see two key events: the US-Russia bilateral treaty, New START, expires on February 5, and in April, New York hosts the Review Conference (RevCon) of the Treaty on the ...

Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than patients who start out with other drugs. Choosing the right drug from the ...

Wisconsin's deer population is estimated to be at a record high of 1.825 million and is especially high in farmland regions. Despite extended seasons and free antlerless tags, hunter participation is ...

A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications. In a recent study, the drug lowered blood pressure and also seemed to ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Fruits like bananas, avocados, pomegranates, and blueberries ...

Like the iPhone 16 series, all of Apple's latest iPhone 17 models include a new Camera Control button (located on the lower right-hand side when holding the phone in portrait mode). The button aims to ...

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The treatment, called baxdrostat, has been hailed as the most ...

A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high, despite taking several existing medicines, according to the results of a Phase III ...

Doctors may soon have a new way to treat high blood pressure, even among people for whom medicines haven’t worked well in the past. Baxdrostat, an experimental medicine made by AstraZeneca, showed ...

Aug. 20 (UPI) --Tight control over blood pressure is not only good for patients, but is also cost-effective health care, a new study says. Controlling blood pressure to below 120 systolic prevents ...

An aggressive blood pressure target of under 120 mm Hg can significantly reduce heart disease risk, researchers found. Despite more side effects and higher costs, the approach proved cost-effective ...